Clinical Trial Update: FTIH Study With GSK958108 [Phase 1]

View source ↗

Summary

This update reports a completed Phase 1 trial of GSK958108 for premature ejaculation, sponsored by GlaxoSmithKline. The study status is listed as completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• GSK958108

Snippet

Sponsor: GlaxoSmithKline | Conditions: Premature Ejaculation | Phase 1 | Status: COMPLETED